Senseonics Holdings (SENS) Revenue Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | 87.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.17% |
| Dec 31, 2025 | 71.82% |
| Sep 30, 2025 | 89.89% |
| Jun 30, 2025 | 36.67% |
| Mar 31, 2025 | 23.97% |
| Dec 31, 2024 | 3.33% |
| Sep 30, 2024 | -30.08% |
| Jun 30, 2024 | 17.91% |
| Mar 31, 2024 | 22.00% |
| Dec 31, 2023 | 44.14% |
| Sep 30, 2023 | 31.91% |
| Jun 30, 2023 | 2,911.68% |
| Mar 31, 2023 | 1,316.78% |
| Dec 31, 2022 | -55.36% |
| Sep 30, 2022 | 1,574.64% |
| Jun 30, 2022 | -68.36% |
| Mar 31, 2022 | -89.74% |
| Dec 31, 2021 | 221.21% |
| Sep 30, 2021 | -64.02% |
| Jun 30, 2021 | 65.90% |
| Mar 31, 2021 | 9,080.65% |
| Dec 31, 2020 | -56.61% |
| Sep 30, 2020 | -82.24% |
| Jun 30, 2020 | -94.33% |
| Mar 31, 2020 | -99.09% |
| Dec 31, 2019 | 24.59% |
| Sep 30, 2019 | -16.27% |
| Jun 30, 2019 | 27.16% |
| Mar 31, 2019 | 16.19% |
| Dec 31, 2018 | 147.03% |
| Sep 30, 2018 | 145.97% |
| Jun 30, 2018 | 345.09% |
| Mar 31, 2018 | 432.73% |
| Dec 31, 2017 | 953.99% |
| Sep 30, 2017 | 5,567.57% |
| Jun 30, 2017 | 4,184.21% |
| Sep 30, 2016 | -2.63% |
| Jun 30, 2016 | -17.39% |